References
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455–61.
Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–18.
Mamtani A, Barrio AV, King TA, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23(11):3467–74.
Montagna G, Mamtani A, Knezevic A, Brogi E, Barrio AV, Morrow M. Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08650-z.
Galimberti V, Ribeiro Fontana SK, Maisonneuve P, et al. Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol. 2016;42(3):361–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Monica Morrow has received speaking honoraria from Genomic Health. Giacomo Montagna was supported by the Ticino Cancer League, the Hanne Liebermann Foundation, the Fondation Ancrage, and the HEMMI-Stiftung.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article, “Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy,” Ann Surg Oncol 2020. https://doi.org/10.1245/s10434-020-08650-z.
Rights and permissions
About this article
Cite this article
Montagna, G., Morrow, M. ASO Author Reflections: Axillary Staging in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy—Beyond Clinical Trials. Ann Surg Oncol 27, 4523–4524 (2020). https://doi.org/10.1245/s10434-020-08693-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08693-2